title: Th22 cell is a gradually proved potential biomarker for acute coronary syndrome.
authors.affiliation: School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Anhui, Hefei 230032, China ; The Key Laboratory of Anti-Inflammatory and Immune, Anhui Medical University, Ministry of Education, Hefei 230032, China ; Department of Cardiology, the First Affiliated Hospital of Anhui Medical University, Hefei 230032, China.
authors.forename: Ying
authors.initials: Y
authors.lastname: Huang
authors.affiliation: School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Anhui, Hefei 230032, China ; The Key Laboratory of Anti-Inflammatory and Immune, Anhui Medical University, Ministry of Education, Hefei 230032, China.
authors.forename: Tao
authors.initials: T
authors.lastname: Xu
authors.affiliation: School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Anhui, Hefei 230032, China ; The Key Laboratory of Anti-Inflammatory and Immune, Anhui Medical University, Ministry of Education, Hefei 230032, China.
authors.forename: Jun
authors.initials: J
authors.lastname: Li
mesh_terms: D054058:Acute Coronary Syndrome / Q000097:blood* / Q000175:diagnosis; D015415:Biomarkers / Q000097:blood*; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology*; D005786:Gene Expression Regulation; D006801:Humans; D007378:Interleukins / Q000378:metabolism*; D009203:Myocardial Infarction / Q000097:blood; D000097043:Interleukin-22
chemical_list: D015415:Biomarkers; D007378:Interleukins; D000097043:Interleukin-22